GC and schizophrenia: Although some proteomic studies have shown no significant difference in VDBP plasma levels in patients with schizophrenia compared with normal controls,49 additional research suggests that the phosphorylation of the VDBP protein in the serum is reduced in individuals with schizophrenia following olanzapine treatment,63 suggesting a possible association between schizophrenia and VDBP levels.